These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 13632729

  • 1. 1, 6-Di(2-bromoethylamino)-1, 6-dideoxy-Dmannitol dihydrobromide: a new cytostatic agent.
    VARGHA L, HORVATH T.
    Nature; 1959 Feb 07; 183(4658):394-5. PubMed ID: 13632729
    [No Abstract] [Full Text] [Related]

  • 2. Effect of 1, 6-di-(2-bromoethylamino)-1, 6-dideoxy-D-mannitol dihydrobromide on tumours of laboratory animals.
    BALO J, KENDREY G, JUHASZ J, BESZNYAK I.
    Nature; 1959 Feb 07; 183(4658):395. PubMed ID: 13632730
    [No Abstract] [Full Text] [Related]

  • 3. [Action of 1,6-bis(2-bromoethylamino)-1,6-didesoxy-D-mannitol dihydrobromide on transplanted animal cancer].
    VIALLIER J, PELLET H.
    C R Seances Soc Biol Fil; 1960 Feb 07; 154():362-5. PubMed ID: 13842055
    [No Abstract] [Full Text] [Related]

  • 4. [Experimenttal studies on the tumor growth-inhibiting effect of DBM (R13) (1,6-bis(2-bromoethylamino)-1,6-desoxy-D-mannitol dihydrobromide)].
    BALO J, KENDREY G, JUHASZ J, BESZNYAK I.
    Orv Hetil; 1960 Jan 31; 101():157-61. PubMed ID: 13796294
    [No Abstract] [Full Text] [Related]

  • 5. Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].
    BALO J, KENDREY G, JUHASZ J, BESZNYAK I.
    Br J Cancer; 1959 Dec 31; 13(4):634-41. PubMed ID: 13848916
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies on a cytostatic mannitol derivative (BCM)].
    ECKHARDT S, HARTAI F, MOLNAR E, SELLEI C.
    Orv Hetil; 1956 Sep 02; 97(36):999-1001. PubMed ID: 13388313
    [No Abstract] [Full Text] [Related]

  • 7. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
    LASZLO J, GRIZZLE J, JONSSON U, RUNDLES RW.
    Cancer Chemother Rep; 1962 Feb 02; 16():247-50. PubMed ID: 14462650
    [No Abstract] [Full Text] [Related]

  • 8. [Experiences with cytostatic therapy].
    WELCKER ER.
    Z Arztl Fortbild (Jena); 1960 Jun 15; 54():699-701. PubMed ID: 13784195
    [No Abstract] [Full Text] [Related]

  • 9. [Cytostatic therapy].
    FLEISCHHACKER H.
    Klin Med Osterr Z Wiss Prakt Med; 1950 Jun 15; 5(6):277-8. PubMed ID: 15437732
    [No Abstract] [Full Text] [Related]

  • 10. [Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
    KELLNER B, NEMETH L.
    Orv Hetil; 1956 Sep 02; 97(36):981-4. PubMed ID: 13388307
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative studies on the effect of dimethanesulfonyl-D-mannitol and mannitol mustard on animal leukemia].
    NEMETH L, GAL F.
    Arzneimittelforschung; 1962 Feb 02; 12():197-8. PubMed ID: 14478984
    [No Abstract] [Full Text] [Related]

  • 12. [On changes in the iron level and serum protein fractions after cytostatic therapy with N-oxide mustard gas and a nitrogen mustard phosphamide ester].
    HENNE HF.
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1961 Feb 02; 297():128-38. PubMed ID: 13713336
    [No Abstract] [Full Text] [Related]

  • 13. [2-Year results of cytostatic follow-up treatment of bronchial carcinoma].
    HENNE HF.
    Med Klin; 1960 May 20; 55():934-6. PubMed ID: 14401046
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacodynamic effect of degranol].
    HADNAGY C, GUNDISCH M, GYERGYAY F, KREPSZ I, EPERJESSY A, KISS A, MALATINSZKY GE, KEMENY G, FESZT T, CSGEDI J.
    Arch Int Pharmacodyn Ther; 1959 Jul 01; 120():334-42. PubMed ID: 13830778
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical experience with degranol].
    CSOMOR G.
    Lijec Vjesn; 1961 Oct 01; 83():1043-51. PubMed ID: 13882540
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical and experimental studies on the effect of the modern cytostatic substances on phagocytic ability of the leukocytes].
    BAER B, ADORF A.
    Klin Wochenschr; 1954 Mar 01; 32(9-10):199-203. PubMed ID: 13153079
    [No Abstract] [Full Text] [Related]

  • 18. [1, 6-Bis(beta-chlorethylamino)-1, 6-desoxy-D-mannit dichlorhydrate (BCM), a new nitrogen derivative].
    KELLNER B, NEMETH L.
    Z Krebsforsch; 1956 Mar 01; 61(2):165-79. PubMed ID: 13353379
    [No Abstract] [Full Text] [Related]

  • 19. Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
    WESTBURY G, HUMBLE JG, NEWTON KA, SKINNER ME, PEGG DE.
    Lancet; 1959 May 09; 1(7080):968-9. PubMed ID: 13655649
    [No Abstract] [Full Text] [Related]

  • 20. [Rhythm produced with cytostatics].
    DERER L, MENKYNA R, NEPEL'OVA L, ORAVEC D.
    Bratisl Lek Listy; 1954 May 09; 34(5):477-84. PubMed ID: 13208885
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.